ArticleP & T : a peer-reviewed journal for formulary management2014

Ibrutinib (imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.

Sapna Parmar et al.PubMed ↗Full text ↗

No numbers read from the abstract.